Helix

$0.00 (0.00%) As of 12:00 AM UTC today

Why Robinhood?

You can watch Helix and buy or sell other stocks, options, and ETFs commission-free!

About HLXA

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.

CEO
Jorge Santos da Silva, PhD
Employees
2
Headquarters
Zug, Zug
Founded
2021

HLXA Key Statistics

Market cap
196.17M
Price-Earnings ratio
—
Dividend yield
—
Average volume
36.95K
High today
—
Low today
—
Open price
—
Volume
0.00
52 Week high
$15.19
52 Week low
$4.25
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure